Alucent raises $35m for natural vascular scaffolding clinical trials
Alucent Biomedical has raised $35m in Series B financing to support the clinical trials of its Alucent Natural Vascular Scaffolding (AlucentNVS) Vessel Restoration System with Photoactivated Linking. The